final final sapporo
TRANSCRIPT
Rigid Endoscopic Resection ofDeep-Seated or
Intraventricular Brain Tumors
“Strong retraction may cause signi�cant brain and vascular damage; tubular retractors can help minimize retraction injury. The rigid endoscopic technique using a thick tubular sheath [VBAS] provides an alternative medial approach that improves visualization and increases working space. We believe that this technique [rigid endoscope resection through a sheath] is a safer, more reliable, and less invasive method for the treatment of deep-seated brain tumors.”
Akiyama Y, Wanibuchi M, Mikami T, Horita Y, Suzuki K, Otaki S, Mikuni N.
VBAS Clinical DataPublished In
NEUROLOGICAL RESEARCH
March 2015 Edition
A) Superficial part of the tumor is visible through the transparent polycarbonate VBAS tubular retractor.B) Pr-op MRI revealing right thalamic low-grade gliomaC) Post-op computed tomography axial images
Sapporo Medical University School of Medicine
View the full article at:Www.vycorvbas.com/clinical-studies
Ph: 561.558.2020Fax: 631.794.2444
Email: [email protected]
THE SAPPORO STUDY DEMONSTRATED:
REQUEST A TRIAL
6401 Congress Avenue Suite 140Boca Raton, FL. 33487www.VycorMedical.com
VBAS – A MINIMALLY INVASIVE BRAIN ACCESS SYSTEM AVAILABLE IN 12 SIZES.
• VBAS can e�ectively be used as a rigid sheath in combination with an endoscope to access deep-seated brain tumors, such as thalamic gliomas and malignant lymphomas.
• Use of the VBAS as a rigid endoscope sheath combined with both an endoscope in conjunction with a navigation system mounted to the tab of the VBAS allows for greater visualization and increases the working space allowing for simultaneous bimanual resection (bipolar forceps and suction).
• Under direct vision using the VBAS as a rigid endoscopic sheath, it is possible to carefully observe the tumor surface and avoid vessels during tumor resections. It is also possible to collect enough specimens for a pathological diagnosis.
• Numerous reports emphasize the bene�t of the translucent tubular VBAS retractor for ventricular and deep seated brain tumors.